189 related articles for article (PubMed ID: 11462037)
21. 2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo.
Zoulim F; Dannaoui E; Borel C; Hantz O; Lin TS; Liu SH; Trépo C; Cheng YC
Antimicrob Agents Chemother; 1996 Feb; 40(2):448-53. PubMed ID: 8834896
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of duck hepatitis B virus replication by 9-(2-phosphonylmethoxyethyl)adenine, an acyclic phosphonate nucleoside analogue.
Nicoll AJ; Colledge DL; Toole JJ; Angus PW; Smallwood RA; Locarnini SA
Antimicrob Agents Chemother; 1998 Dec; 42(12):3130-5. PubMed ID: 9835503
[TBL] [Abstract][Full Text] [Related]
23. [Ultrastructural study of duck hepatitis B virus in biliary epithelial cells of duck liver].
Chen LB
Zhonghua Bing Li Xue Za Zhi; 1990 Dec; 19(4):285-7. PubMed ID: 2081353
[TBL] [Abstract][Full Text] [Related]
24. Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement.
Jilbert AR; Wu TT; England JM; Hall PM; Carp NZ; O'Connell AP; Mason WS
J Virol; 1992 Mar; 66(3):1377-88. PubMed ID: 1738197
[TBL] [Abstract][Full Text] [Related]
25. The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes.
Newbold JE; Xin H; Tencza M; Sherman G; Dean J; Bowden S; Locarnini S
J Virol; 1995 Jun; 69(6):3350-7. PubMed ID: 7745682
[TBL] [Abstract][Full Text] [Related]
26. Superinfection exclusion in duck hepatitis B virus infection is mediated by the large surface antigen.
Walters KA; Joyce MA; Addison WR; Fischer KP; Tyrrell DL
J Virol; 2004 Aug; 78(15):7925-37. PubMed ID: 15254165
[TBL] [Abstract][Full Text] [Related]
27. Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection.
Foster WK; Miller DS; Marion PL; Colonno RJ; Kotlarski I; Jilbert AR
Antimicrob Agents Chemother; 2003 Aug; 47(8):2624-35. PubMed ID: 12878529
[TBL] [Abstract][Full Text] [Related]
28. Duck hepatitis B virus infection, aflatoxin B1 and liver cancer in domestic Chinese ducks.
Cova L; Mehrotra R; Wild CP; Chutimataewin S; Cao SF; Duflot A; Prave M; Yu SZ; Montesano R; Trepo C
Br J Cancer; 1994 Jan; 69(1):104-9. PubMed ID: 8286190
[TBL] [Abstract][Full Text] [Related]
29. The carbocyclic analog of 2'-deoxyguanosine induces a prolonged inhibition of duck hepatitis B virus DNA synthesis in primary hepatocyte cultures and in the liver.
Fourel I; Saputelli J; Schaffer P; Mason WS
J Virol; 1994 Feb; 68(2):1059-65. PubMed ID: 8289335
[TBL] [Abstract][Full Text] [Related]
30. Duck hepatitis B virus DNA in liver, spleen, and pancreas: analysis by in situ and Southern blot hybridization.
Jilbert AR; Freiman JS; Gowans EJ; Holmes M; Cossart YE; Burrell CJ
Virology; 1987 Jun; 158(2):330-8. PubMed ID: 3590623
[TBL] [Abstract][Full Text] [Related]
31. M13 bacteriophage DNA inhibits duck hepatitis B virus during acute infection.
Iizuka A; Watanabe T; Kubo T; Yamamoto M; Ogawa K; Ohkuma T; Kaji A
Hepatology; 1994 May; 19(5):1079-87. PubMed ID: 8175129
[TBL] [Abstract][Full Text] [Related]
32. Comparative activities of several nucleoside analogs against duck hepatitis B virus in vitro.
Yokota T; Konno K; Chonan E; Mochizuki S; Kojima K; Shigeta S; de Clercq E
Antimicrob Agents Chemother; 1990 Jul; 34(7):1326-30. PubMed ID: 2201250
[TBL] [Abstract][Full Text] [Related]
33. Gene expression and active virus replication in the liver after injection of duck hepatitis B virus DNA into the peripheral vein of ducklings.
Tagawa M; Yokosuka O; Imazeki F; Ohto M; Omata M
J Hepatol; 1996 Mar; 24(3):328-34. PubMed ID: 8778201
[TBL] [Abstract][Full Text] [Related]
34. Duck hepatitis B virus infection of non-hepatocytes.
Walter E; Teubner K; Blum HE; Offensperger WB; Offensperger S; Gerok W
Liver; 1991 Feb; 11(1):53-62. PubMed ID: 2046495
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effect of 9-(2-phosphonylmethoxyethyl)-adenine (PMEA) on human and duck hepatitis B virus infection.
Heijtink RA; De Wilde GA; Kruining J; Berk L; Balzarini J; De Clercq E; Holy A; Schalm SW
Antiviral Res; 1993 Jun; 21(2):141-53. PubMed ID: 8338351
[TBL] [Abstract][Full Text] [Related]
36. Glucagon treatment interferes with an early step of duck hepatitis B virus infection.
Hild M; Weber O; Schaller H
J Virol; 1998 Apr; 72(4):2600-6. PubMed ID: 9525576
[TBL] [Abstract][Full Text] [Related]
37. Duck hepatitis B virus infection, aflatoxin B1 and liver cancer in ducks.
Cova L; Duflot A; Prave M; Trepo C
Arch Virol Suppl; 1993; 8():81-7. PubMed ID: 8260880
[TBL] [Abstract][Full Text] [Related]
38. Characterization of a 120-Kilodalton pre-S-binding protein as a candidate duck hepatitis B virus receptor.
Li JS; Tong SP; Wands JR
J Virol; 1996 Sep; 70(9):6029-35. PubMed ID: 8709225
[TBL] [Abstract][Full Text] [Related]
39. Characterization of infectious and defective cloned avian hepadnavirus genomes.
Wildner G; Fernholz D; Sprengel R; Schneider R; Will H
Virology; 1991 Nov; 185(1):345-53. PubMed ID: 1926780
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of duck hepatitis B virus replication by hypericin.
Moraleda G; Wu TT; Jilbert AR; Aldrich CE; Condreay LD; Larsen SH; Tang JC; Colacino JM; Mason WS
Antiviral Res; 1993 Mar; 20(3):235-47. PubMed ID: 8470884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
